pulmonary tuberculosis

Factors Associated with Interruption of Treatment among Pulmonary Tuberculosis Patients in Plateau State – Nigeria, 2011

Introduction: Nigeria has one of the highest tuberculosis (TB) burdens in the world (311/100,000), and the largest in Africa. Multi-drug resistant TB (MDR-TB) is an emerging threat for TB control in Nigeria, caused mainly by incomplete treatment.

Year: 
2011
Author (s): 
Patrick Nguku, Henry Akpan, Suleiman H. Idris

 

Presenter (s): 
Luka Ibrahim
Add files
Conference: 
EIS International Night 2012

Risk factors for tuberculosis treatment failure among pulmonary tuberculosis patients - four health regions of Burkina Faso, 2009

Background: In Burkina Faso, the tuberculosis (TB) treatment failure rate increased from 2.5% in 2000 to 8.3% in 2006. The risk factors for TB treatment failure in the country are not well known. The study aims to determine the risk factors for treatment failure among pulmonary tuberculosis patients in four health region of Burkina Faso and to recommend appropriate interventions.

Year: 
2009
Author (s): 

Bernard Sawadogo1,3, K. Tint1,3, M. Tshimanga1, L. Kuonza1, L. Ouedraogo2 1-South Africa FELTP 2-University of Ouagadougou 3-School of Health Systems and Public Health, University of Pretoria

Presenter (s): 
Sawadogo
Add files

Tuberculosis among Household Contacts of Smear Positive Pulmonary Tuberculosis Patients in Diwaniya Governorate / Iraq-2010

Background: Iraq is among nine high burden TB countries in EMRO, with incidence of 64/100,000. National TB program achieved global cure rate target but case detection rate (CDR) is still low (48%). Investigation of contacts of smear positive pulmonary TB (SPPTB) patients is a strategy to increase CDR.

Objectives: To determine the prevalence and risk factors of TB among household contacts of SPPTB in Diwaniya governorate/ Iraq.

Year: 
2009
Author (s): 

Mekki Braibel MD, Faris Al-Lami MD PhD

Presenter (s): 
al-lami

Delay in Diagnosis and Treatment of Pulmonary Tuberculosis in Mandi district of Himachal Pradesh, India, 2010.

Background: Delay in tuberculosis diagnosis and treatment leads to increased transmission, morbidity and mortality. Delays could be on account of patients as well as providers. We conducted a study to estimate the magnitude of these delays and identify associated factors among the new sputum positive (NSP) patients in Mandi district, Himachal Pradesh.

Year: 
2008
Author (s): 

Rajesh K Thakur, M Murhekar National Institute of Epidemiology, ICMR, Chennai, India

Presenter (s): 
Thakur

Determinants of treatment delay among newly diagnosed pulmonary tuberculosis patients ? Almaty Region, Kazakhstan, 2009

Introduction: Tuberculosis (TB) in Kazakhstan is common. In 2008, 1,338 newly diagnosed TB patients were identified in Almaty Region (notification rate, 104/100,000 population); 500 (37%) were in an advanced stage of pulmonary tuberculosis (PTB) an indication of delay in treatment initiation or diagnosis. To provide recommendations to the TB program, we conducted an investigation to identify the magnitude of treatment delay (TD) and factors associated with it.

Year: 
2008
Author (s): 

Manar Smagul, S Ajeilat

Presenter (s): 
Dr. Manar Smagul
Syndicate content